Marine Drugs

Scope & Guideline

Innovating Therapeutics through Marine Bioactive Compounds

Introduction

Welcome to your portal for understanding Marine Drugs, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherMDPI
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMAR DRUGS / Mar. Drugs
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Marine Drugs' is dedicated to the exploration and advancement of marine-derived compounds with potential therapeutic applications. It serves as a platform for researchers to share their findings on the biochemical properties, pharmacological effects, and innovative applications of marine resources, particularly in the fields of drug discovery and development.
  1. Marine Natural Products:
    Focuses on the discovery and characterization of natural products derived from marine organisms, including algae, sponges, and microorganisms. This area emphasizes the pharmacological potential of these compounds against various diseases.
  2. Biotechnology and Biomedical Applications:
    Explores the biotechnological applications of marine-derived compounds, including their use in drug delivery systems, tissue engineering, and regenerative medicine.
  3. Environmental and Ecological Studies:
    Investigates the ecological roles of marine organisms and their metabolites, including studies on bioaccumulation, environmental impacts, and marine biodiversity.
  4. Pharmacological Studies:
    Includes research on the pharmacodynamics and pharmacokinetics of marine compounds, assessing their therapeutic effects, mechanisms of action, and potential side effects.
  5. Nutraceuticals and Functional Foods:
    Examines the health benefits of marine-derived dietary supplements and functional foods, focusing on their roles in disease prevention and health promotion.
In recent years, 'Marine Drugs' has seen a rise in interest in certain research themes, reflecting emerging trends in the field of marine pharmacology and biotechnology.
  1. Metabolomics and Genomics:
    There is an increasing focus on metabolomics and genomics in the study of marine organisms, which allows for a deeper understanding of biochemical pathways and the discovery of new bioactive compounds.
  2. Sustainable and Eco-Friendly Extraction Methods:
    Research is trending towards the development of sustainable and eco-friendly extraction methods for marine compounds, aligning with global sustainability goals.
  3. Multi-Omics Approaches:
    The application of multi-omics approaches (genomics, proteomics, metabolomics) is gaining traction, enabling comprehensive studies of marine organisms and their potential therapeutic applications.
  4. Marine-Derived Biomaterials:
    There is a growing interest in marine-derived biomaterials for use in tissue engineering and regenerative medicine, highlighting their unique properties and biocompatibility.
  5. Functional Foods and Nutraceuticals:
    The exploration of marine ingredients as functional foods and nutraceuticals is on the rise, with a focus on their health benefits and potential for disease management.

Declining or Waning

While 'Marine Drugs' has a broad scope, certain themes appear to be declining in prominence based on recent publication trends. This could reflect shifts in research focus or saturation in specific areas.
  1. Traditional Medicinal Uses:
    Research on traditional medicinal uses of marine organisms has seen a decline, possibly due to a shift towards more innovative and biotechnologically advanced applications.
  2. Chemical Synthesis of Marine Compounds:
    There is a noticeable decrease in studies focused solely on the chemical synthesis of marine-derived compounds, as more emphasis is placed on bioactivity and natural extraction methods.
  3. Conventional Pharmacological Research:
    Research that primarily focuses on conventional pharmacological testing without integrating modern techniques such as genomics or metabolomics is becoming less common.

Similar Journals

MEDICINE

Advancing medical knowledge for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0025-7974Frequency: 52 issues/year

MEDICINE, published by Lippincott Williams & Wilkins, is an esteemed open access journal in the field of general medicine, holding a significant position with a Scopus rank of #190 out of 636 in its category (2023), placing it in the 70th percentile. Since its inception in 1922, MEDICINE has been a vital platform for researchers, professionals, and students to disseminate groundbreaking findings and advancements in the medical field. With the transition to open access in 2014, the journal ensures that valuable research is readily available to a global audience, fostering collaboration and innovation across diverse medical disciplines. Its current impact factor and influence in the miscellaneous medicine category (Q3) reflect its commitment to supporting rigorous peer-review processes and promoting scholarly excellence. Located in Philadelphia, PA, the journal covers a wide range of topics, making it a crucial resource for those dedicated to the betterment of healthcare and medical education.

Acta Pharmaceutica Sinica B

Connecting Researchers for Groundbreaking Discoveries
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

Advances in Pharmacological and Pharmaceutical Sciences

Bridging Research and Practice in Pharmaceutical Sciences.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

MARINE GEORESOURCES & GEOTECHNOLOGY

Charting New Territories in Georesources and Geotechnology
Publisher: TAYLOR & FRANCIS INCISSN: 1064-119XFrequency: 10 issues/year

MARINE GEORESOURCES & GEOTECHNOLOGY, published by Taylor & Francis Inc, is a premier interdisciplinary journal that addresses critical issues at the intersection of geosciences, engineering, and oceanography. With an ISSN of 1064-119X and E-ISSN 1521-0618, this journal has been pivotal since its inception in 1993, delivering high-quality research through 2024. Recognized for its scholarly impact, it boasts a Q2 ranking in key categories including Geotechnical Engineering, Ocean Engineering, and Oceanography, demonstrating its significance within these fields. The journal features a dynamic range of articles, encompassing both theoretical and application-based studies that contribute to understanding marine resources and geotechnical challenges in various environments. Engaging with MARINE GEORESOURCES & GEOTECHNOLOGY ensures that researchers, professionals, and students remain at the forefront of developments in marine science and technology, while fostering collaboration and innovation in tackling complex geological and oceanographic problems.

Indian Journal of Geo-Marine Sciences

Innovating Insights into Marine Ecosystems and Geology
Publisher: NATL INST SCIENCE COMMUNICATION-NISCAIRISSN: Frequency: 12 issues/year

The Indian Journal of Geo-Marine Sciences, published by the NATIONAL INSTITUTE OF SCIENCE COMMUNICATION & INFORMATICS (NISCAIR), serves as a vital platform dedicated to the dissemination and advancement of knowledge in the field of marine and geosciences. As an open-access journal, it allows for improved visibility and accessibility of research findings to a global audience, enabling researchers, professionals, and students to share insights into oceanography and related disciplines. With a publication history spanning from 2007 to 2010 and continuing from 2012 to 2024, it has established itself within the academic community as a reliable source of innovative research, despite being classified in Q4 of Oceanography and holding a Scopus rank that places it in the 27th percentile. This journal is particularly relevant for those investigating marine ecosystems, geological oceanography, and their interconnections, thus playing an essential role in fostering understanding and communication within this important area of scientific inquiry.

European Journal of Pharmacology

Advancing drug discovery through innovative research.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

ARCHIVES OF PHARMACAL RESEARCH

Showcasing impactful discoveries in organic chemistry and beyond.
Publisher: PHARMACEUTICAL SOC KOREAISSN: 0253-6269Frequency: 12 issues/year

Archives of Pharmacal Research, published by the Pharmaceutical Society of Korea, is a leading journal in the fields of drug discovery, molecular medicine, and organic chemistry. With an illustrious history spanning from 1978 to 2024, this peer-reviewed journal has earned a remarkable reputation, achieving a Q1 category ranking in each of its primary research areas as of 2023. Ranked #9 in Organic Chemistry and #12 in Drug Discovery among their respective fields, Archives of Pharmacal Research showcases cutting-edge research that contributes significantly to scientific advancements. Although it is not an open-access journal, its impactful publications are crucial resources for researchers, professionals, and students navigating the complexities of pharmacological sciences. The journal's continued commitment to disseminating high-quality research underlines its importance in fostering innovation and expanding knowledge within the pharmaceutical landscape.

MARINE BIOTECHNOLOGY

Navigating the Intersection of Sea and Science
Publisher: SPRINGERISSN: 1436-2228Frequency: 6 issues/year

Marine Biotechnology is a premier journal published by Springer, specializing in the interdisciplinary research at the intersection of marine biology and biotechnology. With an ISSN of 1436-2228 and a robust e-ISSN of 1436-2236, this journal has been a cornerstone for scholars and practitioners since its inception in 1999, and is positioned to continue shaping the field through 2024. Recognized for its contributions in Aquatic Science and Biotechnology, it currently holds a Q2 ranking in both categories for 2023, highlighting its relevance and impact within the global scientific community. With a Scopus rank of 64/247 in Aquatic Science and 149/311 in Biotechnology, Marine Biotechnology offers a vital platform for disseminating cutting-edge research that encompasses environmental sustainability, pharmaceutical applications, and bioinformatics. The journal promotes open access to its valuable content, ensuring that research is readily available to a wide audience. By bringing together leading researchers and fostering collaborations, Marine Biotechnology stands as an essential resource for those committed to advancing our understanding of marine resources and their applications in biotechnology.

PLANTA MEDICA

Exploring the Healing Power of Plants
Publisher: GEORG THIEME VERLAG KGISSN: 0032-0943Frequency: 18 issues/year

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

CURRENT MEDICINAL CHEMISTRY

Catalyzing Breakthroughs in Health Sciences.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8673Frequency: 42 issues/year

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.